The Future of the Biologics CDMO Market: Innovation, Expansion, and Industry Trends
The pharmaceutical industry’s shift toward biologic therapeutics has fundamentally reshaped how drugs are developed, produced, and brought to market. At the center of this transformation stands a specialized manufacturing ecosystem built to support the unique demands of biological products — monoclonal antibodies, recombinant proteins, biosimilars, vaccines, and advanced cell and gene therapies. This ecosystem, comprising…
